NervGen Pharma Corp. (NGEN)
2.00
+0.14
(+7.53%)
USD |
NASDAQ |
Aug 24, 16:00
2.08
+0.08
(+4.00%)
After-Hours: 05:03
NervGen Pharma Market Cap : 212.83M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 212.83M |
| August 21, 2026 | 197.93M |
| August 20, 2026 | 187.29M |
| August 19, 2026 | 186.22M |
| August 18, 2026 | 181.97M |
| August 17, 2026 | 178.77M |
| August 14, 2026 | 184.63M |
| August 13, 2026 | 187.29M |
| August 12, 2026 | 187.29M |
| August 11, 2026 | 185.16M |
| August 10, 2026 | 137.68M |
| August 07, 2026 | 138.49M |
| August 06, 2026 | 139.30M |
| August 05, 2026 | 136.06M |
| August 04, 2026 | 134.44M |
| August 03, 2026 | 132.83M |
| July 31, 2026 | 131.21M |
| July 30, 2026 | 129.59M |
| July 29, 2026 | 128.78M |
| July 28, 2026 | 130.40M |
| July 27, 2026 | 132.83M |
| July 24, 2026 | 132.02M |
| July 23, 2026 | 135.66M |
| July 22, 2026 | 139.30M |
| July 21, 2026 | 144.16M |
| Date | Value |
|---|---|
| July 20, 2026 | 140.11M |
| July 17, 2026 | 135.25M |
| July 16, 2026 | 135.25M |
| July 15, 2026 | 136.87M |
| July 14, 2026 | 140.92M |
| July 13, 2026 | 156.31M |
| July 10, 2026 | 152.26M |
| July 09, 2026 | 150.64M |
| July 08, 2026 | 149.83M |
| July 07, 2026 | 162.79M |
| July 06, 2026 | 170.89M |
| July 02, 2026 | 171.70M |
| July 01, 2026 | 169.27M |
| June 30, 2026 | 166.84M |
| June 29, 2026 | 158.74M |
| June 26, 2026 | 151.45M |
| June 25, 2026 | 154.69M |
| June 24, 2026 | 161.17M |
| June 23, 2026 | 166.84M |
| June 22, 2026 | 173.32M |
| June 18, 2026 | 178.18M |
| June 17, 2026 | 177.37M |
| June 16, 2026 | 161.98M |
| June 15, 2026 | 150.64M |
| June 12, 2026 | 155.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 4.739M |
| Milestone Pharmaceuticals, Inc. | 129.48M |
| Clearmind Medicine, Inc. | 1.712M |
| Lexaria Bioscience Corp. | 17.42M |
| Target Group, Inc. (Canada) | 0.6417M |
Market Cap Related Metrics
| PEG Ratio | -0.0388 |
| Price to Book Value | 17.48 |
| Price | 2.00 |
| Earnings Yield | -26.80% |
| PEGY Ratio | -0.0388 |